Table 1.
Patients and tumor characteristics (n = 126)
| Variable | Value (%) |
|---|---|
| Age at diagnosis (years) | |
| Median | 55.7 |
| <50 | 42 (33.3) |
| 50–65 | 50 (39.7) |
| >65 | 34 (27.0) |
| Menopausal status | |
| Pre/perimenopausal | 44 (34.9) |
| Postmenopausal | 82 (65.1) |
| Tumor size | |
| 2 cm | 81 (64.3) |
| >2 cm | 45 (35.7) |
| Histotypes | |
| Ductal carcinoma | 100 (79.4) |
| Lobular carcinoma | 17 (13.5) |
| Other | 9 (7.1) |
| Molecular subtypes | |
| Luminal A‐like | 56 (44.4) |
| Luminal B‐like (HER2 negative) | 31 (24.6) |
| Luminal B‐like (HER2 positive) | 11 (8.7) |
| HER2 positive (non‐luminal) | 6 (4.8) |
| Triple negative (ductal) | 22 (17.5) |
| Tumor grade | |
| 1 | 16 (12.7) |
| 2 | 68 (54.0) |
| 3 | 42 (33.3) |
| Ki‐67 | |
| Low | 68 (54.0) |
| High | 58 (46.0) |
| Patient outcome | |
| Without recurrence | 103 (81.7) |
| Local recurrence | 8 (6.4) |
| Distant recurrence | 15 (11.9) |